Keyword: Third Rock Ventures
John Davis, who headed early clinical development at Pfizer, joined Magenta Therapeutics.
Warp Drive has been working to live up to its name, speeding through development and deals.
Our panel discussed the meaning of good science and how different players can work together to leverage their respective strengths.
PanOptica plans to start trialling the small molecule anti-vascular endothelial growth factor eye drop early next year.
Atlas Venture has made biotech veteran Kevin Bitterman a new partner, joining the firm’s team from Polaris.
Sanofi Genzyme's CEO Meeker will step down amid key rollouts, Allergan's chief strategy officer Patel became CEO at startup Relay, and more.
Third Rock startup Relay Therapeutics has poached Allergan’s EVP and chief strategy officer Sanjiv Patel, M.D., as its new president and CEO.
Upstart Tango stepped up to the dance floor today with a $55 million investment boost from VC Third Rock Ventures as it eyes a new way to help treat cancer.